Patients with antibodies directed against recoverin (a 23 kDa calcium-binding protein) present with visual disturbances that can rapidly progress to blindness. Seropositivity is consistent with cancer-associated retinopathy (CAR). These patients should be evaluated for an underlying small-cell lung carcinoma (SCLC), non-small-cell lung cancer (NSCLC) and neuroendocrine carcinoma.
Serum, EDTA plasma, heparin plasma, citrate plasma, CSF
Immunoblot
Fasting for at least 8-12 hours before sampling
Refer to the Health Service Charter to check storage conditions
+2/+8°C
This test provides the quantitative determination of total tau protein to support the diagnosis of Alzheimer’s disease.
This test provides the quantitative determination of tau protein phosphorylated at threonine 181 (pTau181), to support the diagnosis of Alzheimer’s disease.
Test for the determination of human autoantibodies against NMDAR to support the diagnosis of paraneoplastic neurological syndromes with an intermediate-risk phenotype.
Subscribe to our newsletter to be always updated.